These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 27268638)
1. Robust Reference Intervals for Serum Kappa and Lambda Free Light Chains from a Multi Centre Study Population from Hyderabad, India: Myeloma Diagnostic Implications. Mohammed N; Chandran PA; Kandregula M; Mattaparthi RD; Gundeti S; Volturi J; Darapuneni R; Raju SB; Dattatreya PS Asian Pac J Cancer Prev; 2016; 17(5):2605-10. PubMed ID: 27268638 [TBL] [Abstract][Full Text] [Related]
2. Reference intervals and diagnostic ranges for serum free κ and free λ immunoglobulin light chains vary by instrument platform: Implications for classification of patient results in a multi-center study. Cotten SW; Shajani-Yi Z; Cervinski MA; Voorhees T; Tuchman SA; Korpi-Steiner N Clin Biochem; 2018 Aug; 58():100-107. PubMed ID: 29885308 [TBL] [Abstract][Full Text] [Related]
3. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof]. Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880 [TBL] [Abstract][Full Text] [Related]
4. [The Value of sFLC and Serum Calcium in the Diagnosis and Prognosis of Multiple Myeloma Patients]. Pei XH; Zhang LN; Zhou P; Wang TB; Lian C; Zhang P; Lei PC; Zhu ZM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):794-798. PubMed ID: 38926969 [TBL] [Abstract][Full Text] [Related]
5. Further stratification of patients with multiple myeloma by International Staging System in combination with ratio of serum free κ to λ light chains. Xu Y; Sui W; Deng S; An G; Wang Y; Xie Z; Yao H; Zhu G; Zou D; Qi J; Hao M; Zhao Y; Wang J; Chen T; Qiu L Leuk Lymphoma; 2013 Jan; 54(1):123-32. PubMed ID: 22712834 [TBL] [Abstract][Full Text] [Related]
6. [Measurement of serum free light chains and its clinical significance in 20 newly diagnosed patients of multiple myeloma]. Mao XB; Chen XQ; Zhai YP; Liang R; Gao GX; Ma GG; Yu YP; Li F Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):829-32. PubMed ID: 18718070 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients. García de Veas Silva JL; Bermudo Guitarte C; Menéndez Valladares P; Rojas Noboa JC; Kestler K; Duro Millán R PLoS One; 2016; 11(11):e0166841. PubMed ID: 27893836 [TBL] [Abstract][Full Text] [Related]
8. The association of serum-free light-chain levels with markers of renal function. Erdem BK; Davran F; Yilmaz VT; Çetinkaya R; Akbas H Ren Fail; 2015 Jul; 37(6):1057-60. PubMed ID: 26056734 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used. Bossuyt X; Delforge M; Reynders M; Dillaerts D; Sprangers B; Fostier K; Poesen K; Vercammen M Leukemia; 2018 Aug; 32(8):1815-1818. PubMed ID: 29674643 [No Abstract] [Full Text] [Related]
10. The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease. Molina-Andújar A; Robles P; Cibeira MT; Montagud-Marrahi E; Guillen E; Xipell M; Blasco M; Poch E; Rosiñol L; Bladé J; Quintana LF BMC Nephrol; 2020 Mar; 21(1):111. PubMed ID: 32234026 [TBL] [Abstract][Full Text] [Related]
11. Clinical and preclinical validation of the serum free light chain assay: identification of the critical difference for optimized clinical use. Hansen CT; Münster AM; Nielsen L; Pedersen P; Abildgaard N Eur J Haematol; 2012 Dec; 89(6):458-68. PubMed ID: 22998393 [TBL] [Abstract][Full Text] [Related]
12. Serum free light chain reference intervals in an Optilite and their influence on clinical guidelines. Morales-García LJ; Pacheco-Delgado MS Clin Biochem; 2021 Jun; 92():54-60. PubMed ID: 33662349 [TBL] [Abstract][Full Text] [Related]
13. Establishment and validation of serum free light chain reference intervals in an ethnic Chinese population. Liang YF; Chen WM; Wang QT; Zhai YH; Yang YJ; Liu JY; Levoguer A; Sun WH Clin Lab; 2014; 60(2):193-8. PubMed ID: 24660530 [TBL] [Abstract][Full Text] [Related]
14. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool. Campbell JP; Heaney JL; Shemar M; Baldwin D; Griffin AE; Oldridge E; Goodall M; Afzal Z; Plant T; Cobbold M; Jefferis R; Jacobs JF; Hand C; Drayson MT Clin Chem Lab Med; 2017 Mar; 55(3):424-434. PubMed ID: 27505089 [TBL] [Abstract][Full Text] [Related]
15. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis]. Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626 [TBL] [Abstract][Full Text] [Related]
16. Normalization of free light chain kappa/lambda ratio is a robust prognostic indicator of favorable outcome in patients with multiple myeloma. Iwama K; Chihara D; Tsuda K; Ugai T; Sugihara H; Nishida Y; Yamakura M; Takeuchi M; Matsue K Eur J Haematol; 2013 Feb; 90(2):134-41. PubMed ID: 23210517 [TBL] [Abstract][Full Text] [Related]
17. [Test of Serum Free Light Chain and Its Clinical Significance in Light Chain Multiple Myeloma]. Song P; An ZM; Zhou XG; Li F; Wang LP; Zhao Q; Yu YP; Zhai YP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1357-61. PubMed ID: 26524037 [TBL] [Abstract][Full Text] [Related]
18. [Analysis of serum free light chains κ/λ ratio and heavy/light chain pairs of immunoglobulin to the stratification of multiple myeloma according to Mayo Stratification of Myeloma and Revised International Staging System]. Ščudla V; Balcárková J; Lochman P; Vincová M; Pika T; Minařík J; Zapletalová J; Jarošová M Vnitr Lek; 2016 Apr; 62(4):269-80. PubMed ID: 27250604 [TBL] [Abstract][Full Text] [Related]
19. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920 [TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of serum free light chain in patients with multiple myeloma]. Zhang SS; Wu S; Qu XY; Xu J; Liu P; Lu H; Wu HX; Xu JR; Li JY; Chen LJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):930-5. PubMed ID: 23998588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]